Five Prime Therapeutics Inc (FPRX):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Five Prime Therapeutics Inc (FPRX) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7066
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:44
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Five Prime Therapeutics Inc (Five Prime) is a clinical state biopharmaceutical company focusing on the research and development of novel treatments for cancer and inflammatory disorders. The company’s developmental pipeline is based on the discovery platform and library of therapeutic proteins. The company’s pipeline products include cabiralizumab,; FPA144; FPT-155; FPA-150; FPA-151; Tim- 3 antibody; novel I-O biologics and I-O antibody for treating various forms of cancer. Five Prime has also developed proprietary protein screening technologies and rapid in vivo protein production system to identify new targets for protein therapeutics. The company has development collaborations with companies such as Bristol-Myers Squibb, GlaxoSmithKline, Zai Lab, Galaxy Biotech, BioWa-Lonza and UCB Pharma. Five Prime is headquartered in South San Francisco, California, the US.

Five Prime Therapeutics Inc (FPRX) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Five Prime Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Five Prime Therapeutics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Five Prime Therapeutics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Five Prime Therapeutics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Five Prime Therapeutics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Five Prime Therapeutics Inc, Medical Equipment, Deal Details 10
Partnerships 10
Five Prime Therapeutics Enters into Partnership with Roche 10
Personal Genome Diagnostics Enters into Agreement Five Prime Therapeutics 11
Equity Offering 12
Five Prime Therapeutics Raises USD115 Million in Public offering of Shares 12
Five Prime Therapeutics Completes Private Placement Of Shares For US$21 Million 14
Five Prime Therapeutics Completes Public Offering Of Shares For US$43 Million 15
Five Prime Therapeutics Inc – Key Competitors 16
Five Prime Therapeutics Inc – Key Employees 17
Five Prime Therapeutics Inc – Locations And Subsidiaries 18
Head Office 18
Recent Developments 19
Financial Announcements 19
Aug 08, 2018: Five Prime Therapeutics announces second quarter 2018 financial results 19
May 08, 2018: Five Prime Therapeutics Reports First Quarter 2018 Financial Results 22
Feb 27, 2018: Five Prime Announces Fourth Quarter and Full Year 2017 Financial Results 24
Nov 06, 2017: Five Prime Announces Third Quarter 2017 Results and Provides Business Update 28
May 04, 2017: Five Prime Announces First Quarter 2017 Results and Provides Business Update 30
Feb 23, 2017: Five Prime Announces Fourth Quarter and Full Year 2016 Financial Results 34
Corporate Communications 37
May 15, 2018: Five Prime Therapeutics Appoints Bryan Irving, Ph.D., as Chief Scientific Officer 37
Mar 13, 2018: Five Prime Therapeutics Announces Executive Change 38
Oct 23, 2017: Five Prime Therapeutics Announces Appointment of Aron Knickerbocker as CEO Effective January 1, 2018 39
Aug 17, 2017: Five Prime Therapeutics Announces Addition of Bryan Irving, PhD, as Senior Vice President, Research 40
Jun 21, 2017: Five Prime Therapeutics Announces Lewis T. “Rusty” Williams Plans to Transition from CEO to Executive Chairman of the Board in 2018 41
May 15, 2017: Five Prime Welcomes Garry Nicholson to Board of Directors 42
Mar 20, 2017: Five Prime Therapeutics Announces Executive Changes 43
Appendix 44
Methodology 44
About GlobalData 44
Contact Us 44
Disclaimer 44

List of Tables
Five Prime Therapeutics Inc, Medical Equipment, Key Facts, 2017 2
Five Prime Therapeutics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Five Prime Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Five Prime Therapeutics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Five Prime Therapeutics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Five Prime Therapeutics Inc, Deals By Market, 2012 to YTD 2018 8
Five Prime Therapeutics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Five Prime Therapeutics Enters into Partnership with Roche 10
Personal Genome Diagnostics Enters into Agreement Five Prime Therapeutics 11
Five Prime Therapeutics Raises USD115 Million in Public offering of Shares 12
Five Prime Therapeutics Completes Private Placement Of Shares For US$21 Million 14
Five Prime Therapeutics Completes Public Offering Of Shares For US$43 Million 15
Five Prime Therapeutics Inc, Key Competitors 16
Five Prime Therapeutics Inc, Key Employees 17

List of Figures
Five Prime Therapeutics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Five Prime Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Five Prime Therapeutics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Five Prime Therapeutics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Five Prime Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Five Prime Therapeutics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Five Prime Therapeutics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Five Prime Therapeutics Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Five Prime Therapeutics Inc (FPRX):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Hexcel Corp (HXL):企業の財務・戦略的SWOT分析
    Hexcel Corp (HXL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Raya Holding (RAYA):企業の財務・戦略的SWOT分析
    Raya Holding (RAYA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Philippine Long Distance Telephone Company:企業のM&A・事業提携・投資動向
    Philippine Long Distance Telephone Company - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Philippine Long Distance Telephone Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detai …
  • SomaLogic Inc:企業の製品パイプライン分析2018
    Summary SomaLogic Inc (SomaLogic) is a life science company that discovers, develops and commercializes life science research tools and clinical diagnostic products. The company’s products include SOMAscan assay and SOMAmer reagents. Its SOMAscan reagents is a proteomic platform that combines the pr …
  • Spark Therapeutics Inc (ONCE):企業の財務・戦略的SWOT分析
    Summary Spark Therapeutics Inc (Spark) is a clinical-stage gene therapy company which provides gene therapies for inherited retinal diseases (IRDs), neurodegenerative diseases, as well as liver diseases. Its pipeline products include SPK-RPE65, SPK-CHM, rhonova, LHON, SPK-FIX, SPK-FVIII and SPK-TPP1 …
  • Canon Medical Systems Corp:医療機器:M&Aディール及び事業提携情報
    Summary Canon Medical Systems Corp (Canon Medical Systems), formerly known as Toshiba Medical Systems Corp, a subsidiary of Canon Inc, is a provider of medical diagnostic systems and comprehensive medical solutions. The company’s product portfolio include computed tomography systems, magnetic resona …
  • Yungjin Pharm Co Ltd (003520):企業の財務・戦略的SWOT分析
    Summary Yungjin Pharm Co Ltd (Yungjin), a subsidiary of KT&G Corp is a pharmaceutical company that develops, manufactures and distributes active pharmaceutical ingredients, formulations and tonic drinks. The company provides API products such as cephalosporins and other general products. It also off …
  • Babcock & Wilcox Enterprises Inc (BW):企業の財務・戦略的SWOT分析
    Babcock & Wilcox Enterprises Inc (BW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Kurabo Industries Ltd (3106):企業の財務・戦略的SWOT分析
    Kurabo Industries Ltd (3106) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • General Electric Co (GE)-医療機器分野:企業M&A・提携分析
    Summary General Electric Company (GE) is a digital industrial company. It offers a range of industrial, infrastructure and financial services globally. The company offers a range of products and services from aircraft engines, power generation and oil and gas production equipment to medical imaging, …
  • Egdon Resources Plc Oil & Gas Exploration and Production Operations and Cost Analysis – 2017
    Egdon Resources Plc Oil & Gas Exploration and Production Operations and Cost Analysis - 2017 Summary Egdon Resources Plc (Egdon) is oil and gas company that offers exploration and production services. The company explores and develops petroleum and natural gas assets in East Midlands, North East Eng …
  • Dais Analytic Corps (DLYT):企業の財務・戦略的SWOT分析
    Summary Dais Analytic Corps (Dais) is an alternative energy company that provides industry changing and nano technology based applications. The company's products include ultra capacitors, clean water systems, heating and cooling equipment, among others. It also provides NanoAir, NanoCap, ConsERV an …
  • Public Financial Holdings Ltd (626)
    Public Financial Holdings Ltd (626) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • Synopsys, Inc.:企業のM&A・事業提携・投資動向
    Synopsys, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Synopsys, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • Copenhagen Airports AS:企業の戦略・SWOT・財務情報
    Copenhagen Airports AS - Strategy, SWOT and Corporate Finance Report Summary Copenhagen Airports AS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Chimei Innolux Corporation (3481):企業の財務・戦略的SWOT分析
    Chimei Innolux Corporation (3481) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Cannabics Pharmaceuticals Inc (CNBX):製薬・医療:M&Aディール及び事業提携情報
    Summary Cannabics Pharmaceuticals Inc (Cannabics Pharmaceuticals), formerly Thrust Energy Corp, is a drug development company that develops cannabinoid-based therapies for cancer. The company develops High Content Screening (HCS) Platform, an automated cellular imaging and analysis platform designed …
  • USANA Health Sciences Inc (USNA):企業の財務・戦略的SWOT分析
    USANA Health Sciences Inc (USNA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Sioux Manufacturing Corporation:企業の戦略・SWOT・財務情報
    Sioux Manufacturing Corporation - Strategy, SWOT and Corporate Finance Report Summary Sioux Manufacturing Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Nuclear Power Corporation of India Ltd:企業の戦略的SWOT分析
    Nuclear Power Corporation of India Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and ma …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆